Healthcare -
Biotechnology - NASDAQ - US
$ 8.32
2.4 %
$ 316 M
Market Cap
14.0
P/E
TRDA - OTHER CURRENT LIABILITIES
Other Current Liabilities TRDA - Entrada Therapeutics, Inc.
5.95 M
LAST VALUE
202.84%
2 YEAR CAGR
37.50%
5 YEAR CAGR
0.00%
10 YEAR CAGR